The uses of helium and xenon in current clinical practice

Anaesthesia

Volumn 63, Issue 3, 2008, Pages 284-293

  Harris, P D ^a   Barnes, R ^b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELIOX; HELIUM; XENON;

AIRWAY OBSTRUCTION; ANESTHESIA; AORTA BALLOON; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; HUMAN; HYPERCAPNIA; LAPAROSCOPY; LUNG FUNCTION TEST; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; RESPIRATORY DISTRESS; REVIEW; SKIN CANCER; SKIN DISEASE;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; CHEMISTRY, PHYSICAL; DIAGNOSTIC IMAGING; HELIUM; HUMANS; OXYGEN; RESPIRATORY INSUFFICIENCY; XENON;

EID: 39149102802     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05253.x     Document Type: Review

References (91)

1. Ozima M, Podosek F. Noble Gas Geochemistry. Cambridge : Cambridge University Press, 2006 : 10 6.
2. Gallagher KE, Smith DM, Mellen PF. Suicidal asphyxiation by using pure helium gas: case report, review, and discussion of the influence of the Internet. American Journal of Forensic Medicine and Pathology 2003 24 : 361 3.
3. Tretjak M, Gorjup V, Mozina H, Horvat M, Noc M. Cerebral and coronary gas embolism from the inhalation of pressurized helium. Critical Care Medicine 2002 30 : 1156 7.
4. American Conference of Governmental Industrial Hygienists (ACGIH). Helium Gas. Documentation of the Threshold Limit Values for Chemical Substances. 7th edn. Cincinnati : American Conference of Governmental Industrial Hygienists, 2001.
5. O'Grady K, Doyle DJ, Irish J, Gullane P. Biophysics of airflow within the airway: a review. Journal of Otolaryngology 1997 26 : 123 8.
6. Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Academic Emergency Medicine 1999 6 : 953 6.
7. Kass JE, Terregino CA. The effect of Heliox in acute severe asthma. Chest 1999 116 : 296 300.
8. Xie L, Youning L, Chen L, Hao F, Jin G, Zhao H. Inhaling beta (2)-agonist with heliox-driven in bronchial asthma. Chinese Medical Journal (Engl) 2003 116 : 1011 5.
9. Chien JW, Ciufo R, Novak R, et al. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000 117 : 728 33.
10. Shiue ST, Gluck EH. The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis. Journal of Asthma 1989 26 : 177 80.
11. Hess DR, Acosta FL, Ritz RH, Kacmarek RM, Camargo CA. The effect of Heliox on nebulizer function using a beta-agonist broncodilator. Chest 1999 115 : 184 9.
12. Bag R, Bandi MD, Fromm RE, Guntupalli KK. The effect of Heliox-driven bronchodilator aerosol therapy on pulmonary function tests in patients with asthma. Journal of Asthma 2002 3 : 659 65.
13. Bandi V, Velamuri S, Sirgi C, Wendt J, Wendt R, Guntupalli K. Deposition pattern of heliox-driven bronchodilator aerosol in the airway of stable asthmatics. Journal of Asthma 2005 42 : 583 6.
14. Gerbeaux P, Gainnier M, Boussouges A, et al. Use of heliox in patients with severe exacerbation of chronic obstructive pulmonary disease. Critical Care Medicine 2001 29 : 2322 4.
15. Kukudis TM, Manthous CA, Schmidt GA, Hall JB, Wylam ME. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. Journal of Paediatrics 1997 130 : 217 24.
16. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated asthma patients. Cochrane Database Syst Rev 2003 4. CD002884
17. Kauczor HU, Chen XJ, van Beek EJR, Schreiber WG. Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application. European Respiratory Journal 2001 17 : 1008 23.
18. Davis PD, Parbrook GD, Kenny GNC. Basic Physics and Measurement in Anaesthesia. 4th edn. Oxford : Butterworth-Heinemann Ltd, 1995.
19. West JB. Respiratory Physiology: The Essentials. 7th edn. US : Lippincott Williams & Wilkins, 2004.
20. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. European Respiratory Journal 2005 26 : 511 22.
21. Johnson PL, Sibert KS. Laparoscopy: Gasless vs. CO2 pneumo-peritoneum. Journal of Reproductive Medicine 1997 42 : 255 9.
22. Ordemann J, Hoflich C, Braumann C, Hatmann J, Jacobi CA. Impact of pneumoperitoneum on expression of E-cadherin, CD44v6 and CD54 (ICAM-1) on HT-29 colon-carcinoma cells. Zentralblatt fur Chirugie 2005 130 : 405 9.
23. Bouvy ND, Marquet RL, Jeekel H, Bonjer HJ. Impact of gas (less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Annals of Surgery 1996 224 : 694 700. Discussion 700 1.
24. Paraskeva PA, Ridgway PF, Jones T, Smith A, Peck DH, Darzi AW. Laparoscopic environment changes during surgery enhance the invasive potential of tumours. Tumour Biology 2005 26 : 94 102.
25. Jacobi CA, Sabat R, Bohm B, Zieren HU, Volk HD, Muller JM. Pneumoperitoneum with carbon dioxide stimulates growth of malignant colonic cells. Surgery 1997 121 : 72 8.
26. Bongard FS, Pianim NA, Leighton TA, et al. Helium insufflation for laparoscopic operation. Surgery Gynaecology and Obstetrics 1993 177 : 140 6.
27. Bongard FS, Pianim NA, Liu SY, Lippmann M, Davis I, Klein S. Using helium for insufflation during laparoscopy. JAMA 1991 266 : 3131.
28. Schob OM, Allen DC, Benzel E, et al. A comparison of the pathophysiologic effects of carbon dioxide, nitrous oxide and helium pneumoperitoneum on intracranial pressure. American Journal of Surgery 1996 172 : 248 53.
29. Neuhaus SJ, Ellis T, Pike GK, Rofe AM, Jamieson GG, Watson DI. Tumour implantation following laparoscopy using different insufflation gases. Surgical Endoscopy 1998 12 : 1300 2.
30. Neuhaus SJ, Ellis T, Barrett MW, Rofe AM, Jamieson GG, Watson DI. In vitro inhibition of tumour growth in a helium rich environment-implications for laparoscopic surgery. Australian and New Zealand Journal of Surgery 1999 69 : 52 5.
31. Crabtree JH, Fishman A. Videoscopic surgery under local and regional anaesthesia with helium abdominal insufflation. Surgical Endoscopy 1999 13 : 1035 9.
32. Ludemann R, Krysztopik R, Jamieson GG, Watson DI. Pneumothorax during laparoscopy. Surgical Endoscopy 2003 17 : 1985 9.
33. Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO Journal 2005 51 : 296 300.
34. Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. American Journal of Cardiology 2006 97 : 1391 8.
35. Beckley ML, Ghafourpour KL, Indresano AT. The use of argon beam coagulation to control hemorrhage: a case report and review of the technology. Journal of Oral Maxillofacial Surgery 2004 62 : 615 8.
36. Vargo JJ. Clinical applications of the argon plasma coagulator. Gastrointestinal Endoscopy 2004 59 : 81 8.
37. Willett S. IP Overview: Laparoscopic Helium Plasma Coagulation of Endometriosis. http://www.nice.org.uk/page.aspx?o=IP_167 (accessed 05 June 2006).
38. Chamberlain P. Leak Detection Systems. http://www.lacotech.com/ product_pages/Alcatel_Helium_Leak_Detectors_1554520508.html (accessed on 05 June 2006).
39. Musiol B. Helium Leak Detection Reference. http://www.medivactech.com/ heliumleaktestinginfo.htm (accessed on 05 June 2006).
40. Lumb AB. Principles of measurement of lung volumes. In : Nunn JF ed. Applied Respiratory Physiology. 5th edn. Oxford : Butterworth Heinemann, 2000 : 56 7.
41. Van Liew HD, Paganelli CV, Sponholtz DK. Estimation of gas-phase diffusivities in hyperbaric environments. Undersea Biomedical Research 1982 9 : 175 81.
42. Pyle R. Diving Physics. http://www.iantd.com/rebreather/phys.html (accessed 25 July 2006).
43. Bennett PB. The high-pressure nervous syndrome in man. In : Bennett PB, Elliot DH, eds. The Physiology and Medicine of Diving and Compressed Air Work. London : Balliere-Tindall, 1982 : 262 96.
44. Scott RPW. Gas Chromatography. http://www.chromatography-online.org. (accessed 05 May 2007).
45. Zalutsky MR, Bigner DD. Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates. Acta Oncologica 1996 35 : 373 9.
46. Lide DR. Properties of the Elements and Inorganic Compounds. CRC Handbook of Chemistry and Physics, 87th edn. Florida : CRC Press 2007.
47. Schucht F. Production of anaesthetic gases and environment. Applications in Cardiopulmonary Pathophysiology 2000 9 : 154 5.
48. Goto T, Nakata Y, Morita S. Will xenon be a stranger or a friend? The cost, benefit, and future of xenon anesthesia. Anesthesiology 2003 98 : 1 2.
49. Hanne P, Marx T, Musati S, Santo M, Suwa K, Morita S. Xenon: uptake and costs. International Anaesthesiology Clinics 2001 39 : 43 61.
50. Preckel B, Schlack W. Inert gases as the future inhalational anaesthetics? Best Practice and Research Anaesthesiology 2005 19 : 365 79.
51. Hughes EW. From high-energy physics to medical research... It happens. Engineering and Science 2002 3 : 29 36.
52. Behnke AR, Yarborough OD. Respiratory resistance, oil-water solubility, and mental effects of argon, compared with helium and nitrogen. American Journal of Physiology 1939 126 : 409 15.
53. Lawrence JH, Loomis WF, Tobias CA, Turpin FH. Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. Journal of Physiology 1946 105 : 197 204.
54. Cullen SC, Gross EG. The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951 113 : 580 3.
55. Lachmann B, Armbruster S, Schairer W, et al. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990 335 : 1413 5.
56. Tonner PH. Xenon: one small step for anaesthesia? Current Opinion in Anesthesiology 2006 19 : 382 4.
57. Nakata Y, Goto T, Morita S. Comparison of inhalation inductions with xenon and sevoflurane. Acta Anaesthesioligica 1997 41 : 1157 61.
58. Goto T, Saito H, Shinkai M, Nakata Y, Ichinose F, Morita S. Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. Anesthesiology 1997 86 : 1273 8.
59. Goto T, Saito H, Nakata Y, Uezono S, Ichinose F, Morita S. Emergence times from xenon anaesthesia are independent of the duration of anaesthesia. British Journal of Anaesthesia 1997 79 : 595 9.
60. Nakata Y, Goto T, Ishiguro Y, et al. Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 2001 94 : 611 4.
61. Goto T, Nakata Y, Ishiguro Y, Niimi Y, Suwa K, Morita S. Minimum alveolar concentration-awake of xenon alone and in combination with isoflurane or sevoflurane. Anesthesiology 2000 93 : 1188 93.
62. Burov NE, Kornienko LI, Makeev GN, Potapov VN. Clinical and experimental study of xenon anesthesia. Anesteziologiia i Reanimatoligiia 1999 6 : 56 60.
63. Lane GA, Nahrwold ML, Tait AR, Taylor-Busch M, Cohen PJ, Beaudoin AR. Anesthetics as teratogens: nitrous oxide is fetotoxic, xenon is not. Science 1980 210 : 899 901.
64. Spence AA. Environmental pollution by inhalational anaesthetics. British Journal of Anaesthesia 1987 59 : 96 103.
65. Goto T. Is there a future for xenon anesthesia? [In French] Canadian Journal of Anaesthesia 2002 49 : 335 8.
66. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic and organ-protective actions of xenon. Anesthesiology 2006 105 : 187 97.
67. Aziz T. Xenon in anaesthesia. International Anesthesiology Clinics 2001 39 : 1 14.
68. Suzuki T, Koyama H, Sugimoto M, Uchida I, Masimo T. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine 3 receptors expressed in Xenopus oocytes. Anesthesiology 2002 96 : 699 704.
69. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the inert gas xenon. British Journal of Anaesthesia 2002 89 : 739 46.
70. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine synergistically to provide neuroprotection from neonatal asphyxia. Annals of Neurology 2005 58 : 182 93.
71. Sanders R, Ma D, Maze M. Anaesthesia induced neuroprotection. Best Practice & Research Anaesthesiology 2005 19 : 461 74.
72. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriksen S, Werner O. Left ventricular performance and cerebral haemodynamics during xenon anaesthesia. Anaesthesia 1993 48 : 1045 9.
73. Weber NC, Toma O, Wolter JI, et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-e and p38 MAPK. British Journal of Pharmacology 2005 144 : 123 32.
74. Ishiguro Y. Cardiovascular effects of xenon. International Anesthesiology Clinics 2001 39 : 77 84.
75. Goto T, Suwa K, Uezono S, Ichinose F, Uchiyama M, Morita S. The blood-gas partition coefficient of xenon may be lower than generally accepted. British Journal of Anaesthesia 1998 80 : 255 6.
76. Calzia E, Stahl W, Handschuh T, et al. Continuous arterial pO2 and pCO2 measurements in swine during nitrous oxide and xenon elimination: prevention of diffusion hypoxia. Anesthesiology 1999 90 : 829 34.
77. Baur CP, Klingler W, Jurkat-Rott K, et al. Xenon does not induce contracture in human malignant hyperthermia muscle. British Journal of Anaesthesia 2000 85 : 712 6.
78. Froeba G, Marx T, Pazhur J, et al. Xenon does not trigger malignant hyperthermia in susceptible swine. Anesthesiology 1999 91 : 1047 52.
79. Kunitz O, Baumert JH, Hecker K, et al. Xenon does not prolong neuromuscular block of rocuronium. Anesthesia and Analgesia 2004 99 : 1398 401.
80. Nakata Y, Goto T, Morita S. Vecuronium-induced neuromuscular block during xenon or sevoflurane anaesthesia in humans. British Journal of Anaesthesia 1998 80 : 238 40.
81. Rossaint R, Reyle-Hahn M, Schulte am Esch J, et al. A multicenter randomised comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003 98 : 6 13.
82. Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. British Journal of Anaesthesia 2003 91 : 709 17.
83. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers in Medical Science 2002 17 : 173 86.
84. van Beek E, van Buul MT, Büller H, van Royen E, ten Cate J. The value of lung scintigraphy in the diagnosis of pulmonary embolism. European Journal of Nuclear Medicine 1993 20 : 173 81.
85. Elgazaar A, Silberstein E, Hughes J. Perfusion and ventilation scans in patients with extensive obstructive airway disease: utility of singlebreath (washin) xenon-133. Journal of Nuclear Medicine 1995 36 : 64 7.
86. Chiti A, Schreiner F, Crippa F, Pauwels E, Bombardieri E. Nuclear medicine procedures in lung cancer. European Journal of Nuclear Medicine 1999 26 : 533 55.
87. Wernly JA, DeMeester TR, Kirchner PT, Myerowitz PD, Oxford DE, Golomb HM. Clinical value of quantitative ventilationperfusion lung scans in the surgical management of bronchogenic carcinoma. Journal of Thoracic Cardiovascular Surgery 1980 80 : 535 43.
88. Nagao M, Murase K, Ichiki T, Sakai S, Yasuhara Y, Ikezoe J. Quantitative analysis of technegas SPECT: evaluation of regional severity of emphysema. Journal of Nuclear Medicine 2000 41 : 590 5.
89. Suga K, Nishigauchi K, Kume N, et al. Ventilation abnormalities in obstructive airways disorder: detection with pulmonary dynamic densitometry by means of spiral CT versus dynamic Xe-133 SPECT. Radiology 1997 202 : 855 62.
90. Brett SA. Non-invasive imaging of regional lung function using X-ray computed tomography. Journal of Clinical Monitoring and Computing 2000 16 : 433 42.
91. Yonas H, Pindzola RP, Johnson DW. Xenon/computed tomography cerebral blood flow and its use in clinical management. Neurosurgical Clinics of North America 1996 7 : 605 16.